Abstract
Three-dimensional (3D) bioprinting is emerging as a promising technology for fabricating complex tissue constructs with tailored biological components and properties. Recent advances have enabled scientists to precisely position materials and cells to build functional tissue models for in vitro drug screening and disease modeling. This review presents state-of-the-art 3D bioprinting techniques and discusses the choice of cell sources and biomaterials for building functional tissue models that can be used for personalized drug screening and disease modeling. We focus on 3D-bioprinted liver models, cardiac and skeletal muscle tissues, and cancer models for their promising applications in biomedical research, drug discovery, and other preclinical studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: 3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
